Book Reviews

Autor: R. D. Guttmann, Michael B. Monias, Robert R. Leonard, Robert Van Reen, Evelyn M. Bedard, Robert H. Brown, John B. Lovette, Robert B. Franklin, David Wyatt Aiken, Warren C. Eveland, Conrad C. Gilkison, Edward J. Tomsovic, Joseph W. Batch, Murray Rosen, Chester M. Pierce, Charles F. Behrens, Ray N. Brown, Dorothy N. Zeller, Frank R. Camp, Alan L. Klein, JosÉ A. Rivera, J. F. McCabe, José L. Silva, James A. Tobey

Publikováno v: Military Medicine. 128:824-832

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::daa4af8e2ec942641294443cd55b0ba4
https://doi.org/10.1093/milmed/128.8.824

Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells.

Autor: Crook T; Department of Oncology, The London Clinic, London W1G 6BW, UK., Leonard R; Department of Oncology, Cromwell Hospital, London SW5 0TU, UK., Mokbel K; The London Breast Institute, Princess Grace Hospital, London W1U 5NY, UK., Thompson A; Division of Surgical Oncology, Baylor College of Medicine, Houston, TX 77030, USA., Michell M; National Breast Screening Training Centre, King's College Hospital, London SE5 9RS, UK., Page R; Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA 01609, USA., Vaid A; Department of Medical and Haemato Oncology, Medanta-The Medicity, Gurugram 122001, India., Mehrotra R; Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA., Ranade A; Department of Medical Oncology, Avinash Cancer Clinic, Pune 411030, India., Limaye S; Department of Medical and Precision Oncology, Sir HN Reliance Foundation Hospital and Research Centre, Mumbai 400004, India., Patil D; Department of Research and Innovations, Datar Cancer Genetics, Nasik 422010, India., Akolkar D; Department of Research and Innovations, Datar Cancer Genetics, Nasik 422010, India., Datta V; Department of Research and Innovations, Datar Cancer Genetics, Nasik 422010, India., Fulmali P; Department of Research and Innovations, Datar Cancer Genetics, Nasik 422010, India., Apurwa S; Department of Research and Innovations, Datar Cancer Genetics, Nasik 422010, India., Schuster S; Department of Research and Innovations, Datar Cancer Genetics Europe GmbH, 95488 Eckersdorf, Germany., Srinivasan A; Department of Research and Innovations, Datar Cancer Genetics, Nasik 422010, India., Datar R; Department of Research and Innovations, Datar Cancer Genetics, Nasik 422010, India.

Publikováno v: Cancers [Cancers (Basel)] 2022 Jul 09; Vol. 14 (14). Date of Electronic Publication: 2022 Jul 09.

Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study.

Autor: Blagden SP; Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London, W12 0HS, UK. sarah.blagden@oncology.ox.ac.uk.; Early Phase Clinical Trials Unit, Department of Oncology, Churchill Hospital, Headington, Oxford, OX3 7LE, UK. sarah.blagden@oncology.ox.ac.uk., Rizzuto I; Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London, W12 0HS, UK., Suppiah P; NIHR/Wellcome Trust Imperial CRF, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, London, W12 0HS, UK., O'Shea D; NIHR/Wellcome Trust Imperial CRF, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, London, W12 0HS, UK., Patel M; NIHR/Wellcome Trust Imperial CRF, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, London, W12 0HS, UK., Spiers L; Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London, W12 0HS, UK.; Early Phase Clinical Trials Unit, Department of Oncology, Churchill Hospital, Headington, Oxford, OX3 7LE, UK., Sukumaran A; Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London, W12 0HS, UK., Bharwani N; Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London, W12 0HS, UK.; Department of Radiology, Imperial College Healthcare NHS Trust, London, W12 0HS, UK., Rockall A; Department of Radiology, Imperial College Healthcare NHS Trust, London, W12 0HS, UK., Gabra H; Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London, W12 0HS, UK.; Clinical Discovery Unit, Early Clinical Development, AstraZeneca, Cambridge, UK., El-Bahrawy M; Imperial College London, London, W12 0HS, UK., Wasan H; Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London, W12 0HS, UK., Leonard R; Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London, W12 0HS, UK., Habib N; Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London, W12 0HS, UK., Ghazaly E; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

Publikováno v: British journal of cancer [Br J Cancer] 2018 Oct; Vol. 119 (7), pp. 815-822. Date of Electronic Publication: 2018 Sep 12.

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial.

Autor: Collins K; Centre for Health and Social Care Research, Sheffield Hallam University, Sheffield, UK., Reed M; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Lifford K; Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK., Burton M; Centre for Health and Social Care Research, Sheffield Hallam University, Sheffield, UK., Edwards A; Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK., Ring A; Royal Marsden Hospital, London, UK., Brain K; Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK., Harder H; SHORE-C, University of Sussex, Falmer, Brighton, UK., Robinson T; Department of Cardiovascular Sciences, Leicester Royal Infirmary, Infirmary Square, Leicester, UK., Cheung KL; School of Medicine, University of Nottingham, Royal Derby Hospital Centre, Nottingham, UK., Morgan J; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Audisio R; Department of Surgery, University of Liverpool, Liverpool, UK., Ward S; Department of Health Economics and Decision Science, School for Health and Related Research, University of Sheffield, Sheffield, UK., Richards P; Department of Health Economics and Decision Science, School for Health and Related Research, University of Sheffield, Sheffield, UK., Martin C; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; University of Sheffield, Sheffield, UK., Chater T; Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK., Pemberton K; Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK., Nettleship A; Department of Epigenesys, School for Health and Related Research, University of Sheffield, Sheffield, UK., Murray C; Department of Epigenesys, School for Health and Related Research, University of Sheffield, Sheffield, UK., Walters S; Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK., Bortolami O; Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK., Armitage F; University of Sheffield, Sheffield, UK., Leonard R; Imperial College Healthcare NHS Trust, London, UK., Gath J; Yorkshire and Humberside (formerly North Trent Cancer Network) Consumer Research Panel, Sheffield, UK., Revell D; Yorkshire and Humberside (formerly North Trent Cancer Network) Consumer Research Panel, Sheffield, UK., Green T; Yorkshire and Humberside (formerly North Trent Cancer Network) Consumer Research Panel, Sheffield, UK., Wyld L; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; University of Sheffield, Sheffield, UK.

Publikováno v: BMJ open [BMJ Open] 2017 Jul 31; Vol. 7 (7), pp. e015133. Date of Electronic Publication: 2017 Jul 31.

Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover.

Autor: Wilson C; Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom., Gossiel F; Mellanby Centre for Bone research, Sheffield Medical School, University of Sheffield, Sheffield, United Kingdom., Leonard R; Imperial College, London, United Kingdom., Anderson RA; MRC Centre for Reproductive Health, Queens Medical Research Centre, University of Edinburgh, Edinburgh, United Kingdom., Adamson DJ; Ninewells Hospital and Medical School, Ward 32, University of Dundee, Dundee, United Kingdom., Thomas G; Imperial College, London, United Kingdom., Coleman RE; Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom.

Publikováno v: Journal of bone oncology [J Bone Oncol] 2016 Feb 11; Vol. 5 (1), pp. 43-9. Date of Electronic Publication: 2016 Feb 11 (Print Publication: 2016).